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Abstract 
Review on LIPE, with data on DNA, on the protein 
encoded and where the gene is   implicated 
Keywords 
LIPE; hormone sensitive lipase 
Identity 
Other names 
Lipase, HSL, AOMS4, FPLD6, LHS 
HGNC (Hugo) 
LIPE 
Location 
The human LIPE gene is located on 19q13.2 [Link 
to chromosome band 19q13] 
Local order 
LIPE spans 25,920bp, starts at 42401507 and ends at 
42427426 bp from pter (according to hg38-
Dec_2013). 
Figure 1.  Gene neighbours of LIPE on chromosome 19q13.2 (NCBI Annotation Release 108) 
DNA/RNA Description 
Orientation: Minus strand; 25,920 bases; Exon 
count: 31 (Table 1).  
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Table 1.     31 Exons and their locations for LIPE (from Ensembl) NCBI Homo sapiens Annotation Release 108 
Gene Id   Exon Id Chromosome  Strand  Exon Start   Exon End 
ENSG00000079435   ENSE00001194800   19 - 42401507   42402075 
ENSG00000079435   ENSE00003091115   19 - 42401816   42402075 
ENSG00000079435   ENSE00003004228   19 - 42402037   42402075 
ENSG00000079435   ENSE00003029968   19 - 42402607   42403055 
ENSG00000079435   ENSE00000709262   19 - 42402607   42403031 
ENSG00000079435   ENSE00003099674   19 - 42402673   42403031 
ENSG00000079435   ENSE00000709260   19 - 42405385   42405561 
ENSG00000079435   ENSE00003199240   19 - 42405385   42405837 
ENSG00000079435   ENSE00003007563   19 - 42406161   42406319 
ENSG00000079435   ENSE00000709257   19 - 42406161   42406388 
ENSG00000079435   ENSE00003076590   19 - 42407174   42407226 
ENSG00000079435   ENSE00000709254   19 - 42407174   42407468 
ENSG00000079435   ENSE00003124417   19 - 42407400   42407468 
ENSG00000079435   ENSE00003630092   19 - 42407606   42407791 
ENSG00000079435   ENSE00003654406   19 - 42407606   42407791 
ENSG00000079435   ENSE00003603624   19 - 42407976   42408121 
ENSG00000079435   ENSE00003477031   19 - 42407976   42408121 
ENSG00000079435   ENSE00003202428   19 - 42408087   42408121 
ENSG00000079435   ENSE00003018018   19 - 42408095   42408121 
ENSG00000079435   ENSE00003693446   19 - 42408232   42408322 
ENSG00000079435   ENSE00003608280   19 - 42408232   42408322 
ENSG00000079435   ENSE00003146825   19 - 42408311   42408322 
ENSG00000079435   ENSE00003530964   19 - 42410307   42410842 
ENSG00000079435   ENSE00003532609   19 - 42410307   42410842 
ENSG00000079435   ENSE00003170038   19 - 42410582   42410842 
ENSG00000079435   ENSE00003219943   19 - 42412274   42412347 
LIPE (lipase E, hormone sensitive type)  
 
Atlas Genet Cytogenet Oncol Haematol. 2018; 22(10) 425 
 
ENSG00000079435   ENSE00003155428   19 - 42412365   42412448 
ENSG00000079435   ENSE00003063620   19 - 42422993   42423222 
ENSG00000079435   ENSE00003095994   19 - 42422993   42423203 
ENSG00000079435   ENSE00003221897   19 - 42423419   42424123 
ENSG00000079435   ENSE00001162583   19 - 42426267   42427426 
Transcription 
Human LIPE gene has 9 transcripts (Table 2).  
Table 2.     Transcripts of human LIPE gene (Ensembl annotation Release 85) 
Name   Transcript ID   bp   Translation ID   Protein   Biotype 
LIPE-201   ENST00000244289.8   3813   ENSP00000244289   1076aa   Protein coding 
LIPE-205   ENST00000599783.5   1367   ENSP00000469990   260aa   Protein coding 
LIPE-203   ENST00000597620.5   915   ENST00000597620   305aa   Protein coding 
LIPE-206   ENST00000599918.1   824   ENST00000599918   275aa   Protein coding 
LIPE-202   ENST00000597001.1   759   ENSP00000469268   176aa   Protein coding 
LIPE-204   ENST00000599211.1   738   ENSP00000472531   222aa   Protein coding 
LIPE-208   ENST00000601189.1   335   ENSP00000469030   80aa   Protein coding 
LIPE-209   ENST00000602000.1   722   _   No protein   Processed transcript 
LIPE-207   ENST00000600224.1   812   _   No Protein   Retained intron  
Pseudogene 
LOC106780900 hormone-sensitive lipase 
pseudogene [Equus caballus (horse)] (NCBI Equus 
caballus Annotation Release 103) 
Protein 
Note 
LIPE plays a crucial role in acylglycerol and 
cholesteryl ester hydrolysis in adipose tissue and 
exhibits cholesterol hydrolase activity in 
steroidogenic tissue and macrophages. 
Description 
LIPE is highly expressed in adipose tissue as well as 
in heart and skeletal muscle, pancreatic β-cells, 
placenta, adrenal glands, ovary and testis 
(Haemmerle et al., 2003). 2 isoforms produced by 
alternative splicing (Yeamen et, al., 2004; Holst et 
al., 1996). Isoform 1 : Testicular form also known as 
canonical sequence, composed of 1,076 amino acids, 
has 116,598 Da molecular mass. 
Two testicular forms of LIPE have been 
characterized (Stenson et al., 1996; Mairal et al., 
2002). The 3.9 kb mRNA encodes a 1,076 amino 
acid protein that contains a unique NH2-terminal 
region encoded by exon T1. The 3.3 kb mRNA 
encodes a protein that is identical to the adipocyte 
LIPE form. However, the mRNA species differ in 
their 5' ends. Exon usage is mutually exclusive; exon 
T2 is only transcribed in testis, and exon B is only 
transcribed in Adipose tissue (Lucas et al., 2003). 
Isoform 2 : Adipocyte form, composed of 775 amino 
acids encoded by 9 exons, has 84,128 Da molecular 
mass. 
 
Figure 2.  Genomic organization of the LIPE gene 
coding sequences (red boxes) and untranslated 
regions (grey boxes). Exons T1 and T2 are used in 
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testis. Exons A and B are used in the colon 
adenocarcinoma cell line HT29 and adipose tissue, 
respectively. Exons 1 to 9 are used in all tissues 
expressing LIPE (adapted from Lucas et al., 2003). 
Expression 
A 3.3-kb transcript was detected in mammary gland, 
adrenal gland, adipose tissue and muscle, and both a 
3.3 and 3.9 kb transcripts were found in testis (Holst 
et al. 1996). RNA-seq data from 95 human 
individuals representing 27 different tissues reveal 
biased expression in fat and testis (BioProject: 
PRJEB4337) (Figure 2). 
 
Figure 3.  LIPE tissue expression. RNA-seq data from 27 tissues are reported as mean RPKM (Reads Per 
Kilobase Million), corresponding to mean values of the different individual samples from each tissue type. 
 
Localisation 
Found in cell membrane (UniProtKB-SubCell), 
cytosol (HPA), lipid droplet (UniProtKB-SubCell) 
and high density caveolae (UniProtKB-SubCell). 
Translocates to the cytoplasm from the caveolae 
upon insulin stimulation for lipolysis activation 
(Egan et al., 1992). 
Function 
Hormone sensitive lipase is a lipolytic enzyme of the 
'GDXG' family catalyzing the rate limiting step of 
diacylglycerol and monoacylglycerol lipolysis 
(Stralfors et al., 1978). 
In adipose tissue and heart, it primarily hydrolyzes 
stored triglycerides to free fatty acids, while in 
steroidogenic tissues, it principally converts 
cholesteryl esters to free cholesterol for steroid 
hormone production. LIPE is a multifunctional 
enzyme catalyzing (GO_REF:0000003); 
Diacylglycerol + H2O = monoacylglycerol + a carboxylate.  
Triacylglycerol + H2O = diacylglycerol + a carboxylate.  
Monoacylglycerol + H2O = glycerol + a carboxylate.  
Enzyme is regulated post-transcriptionally. LIPE is 
rapidly activated by cAMP-dependent 
phosphorylation under the influence of 
catecholamines. Dephosphorylation and inactivation 
via protein phosphatases or inhibition of protein 
kinases, are controlled by insulin (Yeamen et al., 
1994). Ser 659 and Ser 660 have been shown as 
phosphorylation sites, for in vitro activation of LIPE 
(Anthonsen et al., 1998). 
Also it has protein binding and protein kinase 
binding function interacting selectively and non-
covalently with any protein of protein complex 
(Aboulaich et al., 2006). 
Homology 
LIPE gene is conserved in chimpanzee, dog, cow, 
mouse, rat, zebrafish and frog (Table 3). 
Table 3.    Pairwise alignment of LIPE gene and protein 
sequences (in distance from human)  
Gene Identity % 
Species Symbol Protein DNA 
H. Sapiens LIPE   
vs. P.troglodytes LIPE 99.0 99.3 
vs. C.lupus LIPE 80.2 84.0 
vs. B.taurus LIPE 85.9 86.2 
vs. M.musculus Lipe 84.3 82.0 
vs. R.norvegicus Lipe 74.9 78.1 
vs. X.tropicalis lipe 62.7 62.3 
vs. D.reriro lipeb 61.7 61.5 
Mutations 
198 missense, 12 truncating and 2 inframe mutations 
of LIPE (cBioPortal). 
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Figure 4.  Mutation types observed in LIPE expression in literature and corresponding color codes are as 
follows: Green:  Missense Mutations, Black:  Truncating Mutations: Nonsense, Nonstop, Frameshift deletion, 
Frameshift insertion, Splice site, Brown:  Inframe Mutations: Inframe deletion, Inframe insertion, Purple:  
Other Mutations: All other types of mutations 
Somatic 
LIPE has 3543 SNPs (Ensembl). 
Arg 309 Cyc polymorphism is associated with an 
increased serum cholesterol levels and type 2 
diabetes (Shimada et al. 1996). 
LIPE i6(CA)n repeat polymorphism is associated 
with type 2 diabetes and obesity (Magré et al. 1998). 
The C-60 G polymorphism is located in the promoter 
region of the LIPE and it is possible that the 
substitution of C with G nucleotide result in a 
decrease in gene expression (Talmud et al. 2001). 
The C-60 G polymorphism in the promoter of LIPE 
is associated with body composition and waist 
circumference (Garenc et al. 2002; Carlsson et al. 
2006). In addition, the C-60 G allele male carriers 
present lower levels of fasting non-esterified fatty 
acid and higher levels of low density lipoprotein 
cholesterol (Talmud et al. 2001). 
Implicated in 
Lipodystrophy, Familial Partial, 6 
(FPLD6) 
A form of lipodystrophy characterized by abnormal 
subcutaneous fat distribution. Affected individuals 
have increased visceral fat, impaired lipolysis, 
dyslipidemia, hepatic steatosis, systemic insulin 
resistance, and diabetes. Some patients manifest 
muscular dystrophy (OMIM:615980). 
Cytogenetics 
Autosomal recessive. Caused by homozygous 
mutation in the LIPE gene. Genomewide 
autozygosity mapping and whole-exome 
sequencing, identified homozygosity for a 2bp 
insertion in the LIPE gene (Farhan et al. 2014). The 
mutation caused a frameshift within the hormone-
sensitive lipase domain predicted to result in a 
premature termination codon with an approximately 
50% loss of the original polypeptide. 
Non-alcoholic Fatty Liver Disease 
(NAFLD) 
NAFLD, defined as hepatic steatosis with an 
intrahepatic triglyceride (TG) content?>?5% of the 
liver volume or weight, develops owing to an 
imbalance between fatty acid (FA) input and output. 
Cytogenetics 
In glucose intolerance state, LIPE promoter (CC + 
GG) contributed the greatest impact on raising serum 
triglyceride followed by fatty liver and Adipose 
insulin resistance (Hsiao et al., 2013). 
Multiple Symmetric Lipomatosis 
Rare condition characterized by the symmetric 
growth of fatty tumors (lipomas) around the neck, 
shoulders, upper arms and/or upper trunk. It most 
often affects men of mediterranean ancestry between 
the ages of 30 and 70 who have a history of alcohol 
abuse. The signs and symptoms vary greatly from 
person to person. Usually, accumulation of fatty 
tissue increases over time and may lead to a loss of 
neck mobility and pain. The lipomas can cause 
physical deformity and peripheral neuropathy, when 
they compress a nerve. 
Cytogenetics 
Exome sequencing identified a novel homozygous 
NC_000019.9:g.42906092C>A variant on 
chromosome 19, leading to a 
NM_005357.3:c.3103G>T nucleotide change in 
coding DNA and corresponding p.(Glu1035*) 
protein change in LIPE gene as the disease-causing 
variant (Zolotov et al., 2017). 
Various Cancers 
LIPE gene expression is altered in number of 
cancers. 
Cytogenetics 
Search in cBioPortal showed that LIPE is altered in 
461 (1.1%) of 40567 sequenced cases / patients 
(Figure 5). 
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Figure 5.  Alteration frequency percentages for indicated cancer types from TCGA (The Cancer Genome Atlas). 
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